Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
eNq1mF1v2jAUhu/5FVHuSYBRoFOg2li7IbUao0WbdoNMclLMgp0e23zs188hVKOTo64GX8Z23nPi8/rxUaKr7Srz1oCCctb3m0HD94DFPKHsse9PH27qPf9qUIuWZE2OlnWDRtBs+V6cESH6fjEbzIEwEfy4u/0E+n1Af1DzIj5fQixfrFOSZsEXIhZ3JC/WeNGa08RbgVzwpO/nSu5HvUhI1FkMNhx/iZzEEIWHkePZ5ax9PB6Fhdh/qCoBeEvYo1EUmJVmrBCBySGR8MhxV5HvOyttKiYguMIYxkQuxsjXNIHEGCIlmQCrIOkmuQdcZyCLIEbxcBmvhJU4WZLtBJ5G5qQ/6Nmh3Mp6o97sdtuNTq/T7Vw2Wlah8GirzFXQHxHGs0671Ws2QmBhynHFCUXL2ow5SpI5qgoVw5fGchQH4enV6idU5BnZBUuR224VQaKnAfXxd/chxRc8oAZSpvfsH32msix8Y9bTAy4cZVzQaMgVkxXUuJnYbsSQMwnb6oragU5uD16kIM4n+5szM+THap7R2BZpGjoKhJxORtVEOycMPhIBU3RHg++UJXwjzk+Z46o6yj7fg9IommPSnLUue53mxYX1IfqpLVRxw1wr5DmEmj9UnIKVEUv5qUDRrjRLPXvybHbc9zk8JhlUdDp1S7ZoHz43Zs6c7u4UlRNG0c/XD7b2+KYAd/f7R6M0TfrPhbXjrguYay9W5v12Z5cH3EkLrNAMjoWUuXgfhpvNJlgQURdE71KQ4tnBfnSXumvAnVzYZQNTwtFR6vPy1ntbhWwP2mtX+qlt6uH9QztsjCFRwQm1KJnsjJyj6/PD+G+P6izt8Qt6uAuz7yeJpJy56nPU3Kh4Ev51WdkNaj58TVNa8T+k0pZRWP6LGdSisPgPM6j9AbLO5S8=
C1MzCwb9JFTCK6yQ
